Hello, You are welcome. Let’s talk about Artificial Intelligence in clinical research. Artificial intelligence (AI), also known as machine intelligence, is a branch of computer science that focuses on building and managing technology. They are capable of learning to freely make decisions and carry out actions on behalf of a human being – Techopedia. Huge […]
Clinical trial statistics: what are they? In case you are wondering, they give us the insights we need to come up with better solutions for the future! Now there must be a research body that would conduct all these clinical trials, right? This is where Xcene Research comes into play. We take these data points,
On 28 September 2021, Xcene Research took part in sensitizing and raising awareness for World Heart Day through a webinar tagged “Use Heart To Beat Cardiovascular Disease.” Here are excerpts from thought-provoking presentations delivered by two of our speakers. Dr. Folasade Olugbemi-Paul Hypertension is BP >140/90 mmHg measured on at least 2 different occasions. It
Orphan drugs are medicinal products intended for the diagnosis, prevention, or treatment of life-threatening or very serious diseases or disorders that are rare. A disease or disorder is defined as rare when it affects less than 1 in 2,000 citizens, some rare diseases include Moebius syndrome, Stoneman syndrome, alkaptonuria. These drugs are called “orphans” because,
A rare disease is any disease that affects a small percentage of people in a population. While no universal ratio exists, many countries or regions identify the prevalence of such conditions based on their environment. For instance in the European Union (EU), a disease is classified as a rare disease if it affects fewer than
“Wherever the art of medicine is loved, there is also a love of humanity” – Hippocrates When new drugs, vaccines, and medical devices are developed and marketed, one of the most important things to address is safety—the tracking of adverse events related to the usage of medicinal products. But what goes on behind the scenes
Clinical Trials vs. Clinical Research: What’s to Know? Read More »
After her father passed away, Halima requested his autopsy certificate to understand the cause of death. It was liver cancer. She feels stifled by the lack of willingness of her family to talk about hepatitis B, and wonders if old superstitions in her country about the disease are not contributing to the stigma associated with
Hepatitis: The Need to Accelerate Medical Interventions Read More »
Sickle Cell Disease (SCD) is a hereditary disorder of hemoglobin. It is characterized by severe hemolytic anemia with a range of clinical manifestations such as anemia, periodic episodes of pain (pain crises), frequent infections, and delayed growth or puberty among other symptoms. More people in Africa suffer from SCD than in other parts of the
The evolution of clinical research traverses a long and fascinating journey. The recorded history of clinical trials goes back to the biblical descriptions in 500 BC. The journey moves from dietary therapy – legumes and lemons – to drugs. After the basic approach of the clinical trial was described in the 18th century, efforts were
The Impact Africa Summit (IAS) a brainchild of Nigeria’s foremost contract research organization is designed to initiate strategic interactions and forge collaborations for excellence within the clinical research industry for Africa. The goal of the Impact Africa Summit is to build a network of industry experts and stakeholders to help achieve sustainable capacity for pharmaceutical
